Search for Clinical Trial Results
Agranulocytosis - 258 Studies Found
Status | Study |
Recruiting |
Study Name: Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia Condition: Early Stage Breast Cancer Date: 2016-06-24 Interventions:
|
Not yet recruiting |
Study Name: Pegteograstim in Children With Solid Tumors Condition:
Date: 2016-05-24 Interventions: Drug: Pegteograstim |
Completed |
Study Name: A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen) Condition: Neutropenia (Low White Blood Cell Count) Date: 2016-05-06 Interventions:
|
Completed |
Study Name: A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen) Condition: Neutropenia (Low White Blood Cell Count) Date: 2016-05-06 Interventions:
|
Not yet recruiting |
Study Name: The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia Condition: Breast Cancer Date: 2016-04-28 Interventions: Drug: PEG-rhG-CSF PEG-rhG-CSF 6mg is given for patients Greater than or equal to 45 kg, 3mg is given for |
Not yet recruiting |
Study Name: Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis Condition: Neutropenia Date: 2016-04-28 Interventions: Drug: Lozanoc 65 mg Other Name: itraconazole |
Completed |
Study Name: Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers Condition: Chemotherapy-Induced Neutropenia Date: 2016-01-20 Interventions:
|
Recruiting |
Study Name: Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects Condition: Chemotherapy-induced Neutropenia Date: 2015-11-30 Interventions: Biological: GW003 single SC injection |
Completed |
Study Name: A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants Condition: Neutropenia Date: 2015-12-10 Interventions:
|
Recruiting |
Study Name: Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg Condition: Neutropenia Date: 2015-12-02 Interventions:
|